SKIP X

BioPacific Conference 2012

BioPacific Conference 2012

14th Annual Conference of the Chinese-American Biopharmaceutical Society
(http://www.biopacificconference.org)

The BioPacific Conference is the flagship event of the Chinese-American Biopharmaceutical Society (CABS), with over 500 participants from the US and China each year. This year's theme is "Changing Landscape of Global Biopharmaceutical R&D Innovation and Collaboration," featuring many outstanding and internationally recognized industry leaders, entrepreneurs and scholars as speakers and panelists. The agenda will focus on emerging trends in the industry across the Pacific Ocean, including:

  • Industrial trends and global strategies for R&D innovation
  • Recent breakthroughs in biomedical research and drug discovery
  • Emerging R&D business models and directions in US/China collaboration
  • Legal, regulatory, and cultural considerations in developing drug products in the US and China

In recent years, CABS has played an increasingly important role in bridging the biopharmaceutical communities across the Pacific Ocean. In particular, the BioPacific Conference serves as an important venue for peer-to-peer networking to exchange ideas for new projects and to recruit talents.

The BioPacific Conference 2012 will bring an exciting array of topics on biomedical research, biopharmaceutical R&D and U.S.-China collaborations. The following distinguished scientists, entrepreneurs and leaders have already agreed to speak at the BioPacific Conference 2012:

Philip Beachy, Ernest and Amelia Gallo Professor, Stanford University School of Medicine, Investigator, HHMI
Keting Chu, VP, Leukemia & Lymphoma Society
Qing Dong, CSO, Shanghai Hengrui Pharmaceutical Co.
Kenneth Hillan, CEO/CMO, Achaogen
Peter Hirth, CEO, Plexxikon
Sasha Kamb, Senior VP, Discovery Research, Amgen
Ann Lee, SVP, Genentech, Head of Global Technical Development, Roche
Rick Lindberg, Head of Pfizer CTI
Susan Molineaux, founder and CEO, Calithera
Rusty Williams, CEO, FivePrime
Jingren Xu Chairman and CEO, Yangzijiang
Guo-Liang Yu, CEO and Chairman, Epitomics
Zhenping Zhu, Executive Vice President, Global Biopharmaceuticals, Kadmon Corporation, and President and CEO of Kadmon China

Event Details

2 June 2012
9:00am - 9:00pm

Crowne Plaza Hotel, 1221 Chess Drive, Foster City, California

Early bird prices (before May 19): Active Members $35, Active Members/Postdoc Members $25, Active Sister Org Members $47, Non-Members $55, Student/postdoc non-members $35